In the dose reduction group , TNF inhibitor use could successfully be stopped in 20 % ( 95 % confidence interval 13 % to 28 % ) , the injection interval successfully increased in 43 % ( 34 % to 53 % ) , but no dose reduction was possible in 37 % ( 28 % to 46 % ) .